Publicaciones en las que colabora con Ángela Peñalva Maqueda (7)

2001

  1. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients

    Clinical Endocrinology, Vol. 54, Núm. 4, pp. 509-513

1998

  1. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels

    Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530

  2. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 12, pp. 4350-4354

1996

  1. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli

    Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 909-913

  2. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression

    Journal of Clinical Endocrinology and Metabolism, Vol. 81, Núm. 3, pp. 914-918

1995

  1. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects

    Metabolism, Vol. 44, Núm. 6, pp. 745-748

1993

  1. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 76, Núm. 4, pp. 819-823